Search hospitals
>
New Mexico
>
Albuquerque
Presbyterian Kaseman Hospital
Claim this profile
Albuquerque, New Mexico 87110
Global Leader in Breast Cancer
Global Leader in Breast cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
80 reported clinical trials
12 medical researchers
Summary
Presbyterian Kaseman Hospital is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Presbyterian Kaseman Hospital is involved with conducting 80 clinical trials across 201 conditions. There are 12 research doctors associated with this hospital, such as Atul Kumar, Carolyn Y. Muller, Ursa A. Brown-Glaberman, and Neda Hashemi Sadraei.
Area of expertise
Breast Cancer
Presbyterian Kaseman Hospital has run 34 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Presbyterian Kaseman Hospital has run 25 trials for Breast cancer. Some of their research focus areas include:
Top PIs
Atul Kumar
University of New Mexico Cancer Center
5 years of reported clinical research
Carolyn Y. Muller
University of New Mexico Cancer Center
1 year of reported clinical research
Ursa A. Brown-Glaberman
University of New Mexico Cancer Center
6 years of reported clinical research
Neda Hashemi Sadraei
University of New Mexico Cancer Center
5 years of reported clinical research
Clinical Trials running at Presbyterian Kaseman Hospital
Lung Cancer
Breast Cancer
Bladder Cancer
Uterine Cancer
Breast cancer
Multiple Myeloma
Cancer
Colorectal Cancer
Pancreatic Cancer
Lymphoma
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Presbyterian Kaseman Hospital?
Presbyterian Kaseman Hospital is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Presbyterian Kaseman Hospital is involved with conducting 80 clinical trials across 201 conditions. There are 12 research doctors associated with this hospital, such as Atul Kumar, Carolyn Y. Muller, Ursa A. Brown-Glaberman, and Neda Hashemi Sadraei.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.